351 - 400 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Neuropathological evidence of body-first vs. brain-first Lewy body diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 161Issue #:Start Page: 105557End Page: 105557Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105557Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105557Citation Count: 87
-
RESTRICTEDTitle: Immune responses in the Parkinson's disease brainJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105700End Page: 105700Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105700Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105700Citation Count: 35
-
RESTRICTEDTitle: Treatment of Nonmotor Symptoms Associated with Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 269End Page: 292Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2019.12.003Citation Count: 25
-
RESTRICTEDTitle: LRRK2 as a target for modulating immune system responsesJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 169Issue #:Start Page: 105724End Page: 105724Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105724Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105724Citation Count: 14
-
RESTRICTEDTitle: Understanding the potential causes of gastrointestinal dysfunctions in multiple system atrophyJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 187Issue #:Start Page: 106296End Page: 106296Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2023.106296Best OA location URL: https://doi.org/10.1016/j.nbd.2023.106296Citation Count: 1
-
RESTRICTEDTitle: Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 170Issue #:Start Page: 105744End Page: 105744Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105744Citation Count: 16
-
RESTRICTEDTitle: The roles of connectivity and neuronal phenotype in determining the pattern of α-synuclein pathology in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 168Issue #:Start Page: 105687End Page: 105687Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105687Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105687Citation Count: 14
-
RESTRICTEDTitle: Surgical Treatment of Parkinson DiseaseJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 293End Page: 307Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.001Best OA location URL: http://manuscript.elsevier.com/S0733861920300013/pdf/S0733861920300013.pdfCitation Count: 13
-
RESTRICTEDTitle: Treatment of Tardive DyskinesiaJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 379End Page: 396Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.004Citation Count: 27
-
RESTRICTEDTitle: An Overview of the Current State and the Future of Ataxia TreatmentsJournal Name: Neurologic ClinicsPublisher: Elsevier BVVol: 38Issue #: 2Start Page: 449End Page: 467Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ncl.2020.01.008Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220524Citation Count: 13
-
RESTRICTEDTitle: Neuroimaging the consciousness of self: Review, and conceptual-methodological frameworkJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 112Issue #:Start Page: 164End Page: 212Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.neubiorev.2020.01.023Best OA location URL: https://doi.org/10.1016/j.neubiorev.2020.01.023Citation Count: 109
-
RESTRICTEDTitle: An updated reappraisal of synapsins: structure, function and role in neurological and psychiatric disordersJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 130Issue #:Start Page: 33End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neubiorev.2021.08.011Citation Count: 24
-
RESTRICTEDTitle: Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathiesJournal Name: The FASEB JournalPublisher: WileyVol: 27Issue #: 9Start Page: 3424End Page: 3429Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1096/fj.12-223842Best OA location URL: https://doi.org/10.1096/fj.12-223842Citation Count: 60
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: function in cells and neurodegenerationJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6436End Page: 6444Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07342.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1742-4658.2009.07342.xCitation Count: 32
-
RESTRICTEDTitle: LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic rolesJournal Name: The FEBS JournalPublisher: WileyVol: 276Issue #: 22Start Page: 6445End Page: 6454Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1742-4658.2009.07343.xBest OA location URL: https://europepmc.org/articles/pmc2827245?pdf=renderCitation Count: 21
-
RESTRICTEDTitle: Bent out of shape: α‐Synuclein misfolding and the convergence of pathogenic pathways in Parkinson's diseaseJournal Name: FEBS LettersPublisher: WileyVol: 589Issue #: 24PartAStart Page: 3749End Page: 3759Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.febslet.2015.10.023Best OA location URL: https://febs.onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.febslet.2015.10.023Citation Count: 55
-
RESTRICTEDTitle: Cellular processes associated with LRRK2 function and dysfunctionJournal Name: The FEBS JournalPublisher: WileyVol: 282Issue #: 15Start Page: 2806End Page: 2826Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/febs.13305Best OA location URL: https://doi.org/10.1111/febs.13305Citation Count: 133
-
RESTRICTEDTitle: PINK1 and Parkin – mitochondrial interplay between phosphorylation and ubiquitylation in Parkinson's diseaseJournal Name: The FEBS JournalPublisher: WileyVol: 282Issue #: 2Start Page: 215End Page: 223Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/febs.13127Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/febs.13127Citation Count: 86
-
RESTRICTEDTitle: Endoplasmic Reticulum-Based Calcium Dysfunctions in SynucleinopathiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.742625Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.742625/pdfCitation Count: 10
-
RESTRICTEDTitle: The Role of microRNAs in Mitochondria: Small Players Acting WideJournal Name: GenesPublisher: MDPI AGVol: 5Issue #: 4Start Page: 865End Page: 886Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes5040865Best OA location URL: https://www.mdpi.com/2073-4425/5/4/865/pdf?version=1411736411Citation Count: 116
-
RESTRICTEDTitle: Identifying Risk Genes and Interpreting Pathogenesis for Parkinson’s Disease by a Multiomics AnalysisJournal Name: GenesPublisher: MDPI AGVol: 11Issue #: 9Start Page: 1100End Page: 1100Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes11091100Best OA location URL: https://www.mdpi.com/2073-4425/11/9/1100/pdf?version=1600677065Citation Count: 14
-
RESTRICTEDTitle: Where attention falls: Increased risk of falls from the converging impact of cortical cholinergic and midbrain dopamine loss on striatal functionJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 257Issue #:Start Page: 120End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2014.04.032Best OA location URL: https://europepmc.org/articles/pmc4348073?pdf=renderCitation Count: 92
-
RESTRICTEDTitle: Targeting urate to reduce oxidative stress in Parkinson diseaseJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 298Issue #:Start Page: 210End Page: 224Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.expneurol.2017.06.017Best OA location URL: http://manuscript.elsevier.com/S0014488617301577/pdf/S0014488617301577.pdfCitation Count: 103
-
RESTRICTEDTitle: Monogenic Parkinson’s Disease: Genotype, Phenotype, Pathophysiology, and Genetic TestingJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 3Start Page: 471End Page: 471Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13030471Best OA location URL: https://www.mdpi.com/2073-4425/13/3/471/pdf?version=1646672241Citation Count: 47
-
RESTRICTEDTitle: AAV Vector-Mediated Gene Delivery to Substantia Nigra Dopamine Neurons: Implications for Gene Therapy and Disease ModelsJournal Name: GenesPublisher: MDPI AGVol: 8Issue #: 2Start Page: 63End Page: 63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes8020063Best OA location URL: https://www.mdpi.com/2073-4425/8/2/63/pdf?version=1486965246Citation Count: 45
-
RESTRICTEDTitle: The advent of AAV9 expands applications for brain and spinal cord gene deliveryJournal Name: Expert Opinion on Biological TherapyPublisher: Informa HealthcareVol: 12Issue #: 6Start Page: 757End Page: 766Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1517/14712598.2012.681463Best OA location URL: https://europepmc.org/articles/pmc3361729?pdf=renderCitation Count: 119
-
RESTRICTEDTitle: Alzheimer's Disease and Its Potential Alternative Therapeutics.Journal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4172/2161-0460.1000477Citation Count: 11
-
RESTRICTEDTitle: Remote delivery of cognitive behavioral therapy to patients with functional neurological disorders: Promise and challengesJournal Name: Epilepsy & Behavior ReportsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100469End Page: 100469Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebr.2021.100469Best OA location URL: https://doi.org/10.1016/j.ebr.2021.100469Citation Count: 15
-
RESTRICTEDTitle: The microtubule associated protein tau H1 haplotype and risk of essential tremorJournal Name: European Journal of NeurologyPublisher: WileyVol: 21Issue #: 7Start Page: 1044End Page: 1048Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.12335Best OA location URL: https://europepmc.org/articles/pmc4057305?pdf=renderCitation Count: 12
-
RESTRICTEDTitle: Tau acts as a mediator for Alzheimer's disease‐related synaptic deficitsJournal Name: European Journal of NeurosciencePublisher: WileyVol: 39Issue #: 7Start Page: 1202End Page: 1213Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.12504Best OA location URL: https://europepmc.org/articles/pmc3983570?pdf=renderCitation Count: 44
-
RESTRICTEDTitle: Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson’s DiseaseJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 13678End Page: 13678Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232213678Best OA location URL: https://www.mdpi.com/1422-0067/23/22/13678/pdf?version=1668567593Citation Count: 6
-
RESTRICTEDTitle: Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment StrategyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 23Issue #: 22Start Page: 14340End Page: 14340Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms232214340Best OA location URL: https://www.mdpi.com/1422-0067/23/22/14340/pdf?version=1669106553Citation Count: 8
-
RESTRICTEDTitle: Immune system responses in Parkinson's disease: Early and dynamicJournal Name: European Journal of NeurosciencePublisher: WileyVol: 49Issue #: 3Start Page: 364End Page: 383Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ejn.14290Best OA location URL: https://europepmc.org/articles/pmc6391192?pdf=renderCitation Count: 107
-
RESTRICTEDTitle: Scalable approaches for functional analyses of whole-genome sequencing non-coding variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: R1Start Page: R62End Page: R72Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac191Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585666Citation Count: 4
-
RESTRICTEDTitle: Emerging regenerative medicine and tissue engineering strategies for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0105-5Best OA location URL: https://www.nature.com/articles/s41531-019-0105-5.pdfCitation Count: 50
- Mining genetic and transcriptomic data using machine learning approaches in Parkinson’s disease2020RESTRICTEDTitle: Mining genetic and transcriptomic data using machine learning approaches in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 6Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-020-00127-wBest OA location URL: https://www.nature.com/articles/s41531-020-00127-w.pdfCitation Count: 32
-
RESTRICTEDTitle: Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?Journal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00170-1Best OA location URL: https://www.nature.com/articles/s41531-021-00170-1.pdfCitation Count: 47
-
RESTRICTEDTitle: A systematic review on exercise and training-based interventions for freezing of gait in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00224-4Best OA location URL: https://www.nature.com/articles/s41531-021-00224-4.pdfCitation Count: 49
-
RESTRICTEDTitle: Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological PsychiatryJournal Name: The World Journal of Biological PsychiatryPublisher: Informa UK LimitedVol: 19Issue #: 4Start Page: 244End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15622975.2017.1375556Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15622975.2017.1375556?needAccess=trueCitation Count: 225
-
RESTRICTEDTitle: Bypassing the blood–brian barrier using established skull base reconstruction techniquesJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 1Issue #: 1Start Page: 11End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.wjorl.2015.09.001Best OA location URL: https://doi.org/10.1016/j.wjorl.2015.09.001Citation Count: 7
-
RESTRICTEDTitle: GLP-1 receptor agonists for Parkinson's diseaseJournal Name: Cochrane Database of Systematic ReviewsPublisher: WileyVol: 2020Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/14651858.cd012990.pub2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390475Citation Count: 38
-
RESTRICTEDTitle: The Emerging Role of the Lysosome in Parkinson’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 9Issue #: 11Start Page: 2399End Page: 2399Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells9112399Best OA location URL: https://www.mdpi.com/2073-4409/9/11/2399/pdf?version=1604479812Citation Count: 74
-
RESTRICTEDTitle: Interventions for preventing falls in Parkinson's diseaseJournal Name: Cochrane Database of Systematic ReviewsPublisher: WileyVol: 2022Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/14651858.cd011574.pub2Best OA location URL: https://repository.ubn.ru.nl/bitstream/handle/2066/252084/1/252084.pdfCitation Count: 38
-
RESTRICTEDTitle: Association of Essential Tremor With Novel Risk LociJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 185End Page: 185Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4781Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2787239/jamaneurology_liao_2022_oi_210083_1644604359.06757.pdfCitation Count: 21
-
RESTRICTEDTitle: Alzheimer's disease research progress in Australia: The Alzheimer's Association International Conference Satellite Symposium in SydneyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 1Start Page: 178End Page: 190Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12380Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12380Citation Count: 6
-
RESTRICTEDTitle: Current directions in tau research: Highlights from Tau 2020Journal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 5Start Page: 988End Page: 1007Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12452Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12452Citation Count: 46
-
RESTRICTEDTitle: Genetic architecture of Parkinson’s disease subtypes – Review of the literatureJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.1023574Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.1023574/pdfCitation Count: 19
-
RESTRICTEDTitle: Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 4Start Page: 824End Page: 857Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12422Best OA location URL: https://escholarship.org/content/qt6rm979w3/qt6rm979w3.pdf?t=rffe31Citation Count: 65
-
RESTRICTEDTitle: The Disease Modification Conundrum in Parkinson’s Disease: Failures and HopesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.810860Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.810860/pdfCitation Count: 22
-
RESTRICTEDTitle: Advantages and Recent Developments of Autologous Cell Therapy for Parkinson’s Disease PatientsJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2020.00058Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2020.00058/pdfCitation Count: 28